Abstract
AbstractAccording to the World Health Organization (WHO) data from 2000 to 2019, the number of people living with Diabetes Mellitus and Chronic Kidney Disease (CKD) is increasing rapidly. It is observed that Diabetes Mellitus increased by 70% and ranked in the top 10 among all causes of death, while the rate of those who died from CKD increased by 63% and rose from the 13th place to the 10th place. In this work, we combined the drug dose prediction model, drug-drug interaction warnings and drugs that potassium raising (K-raising) warnings to create a novel and effective ontology-based assistive prescription recommendation system for patients having both Type-2 Diabetes Mellitus (T2DM) and CKD. Although there are several computational solutions that use ontology-based systems for treatment plans for these type of diseases, none of them combine information analysis and treatment plans prediction for T2DM and CKD. The proposed method is novel: (1) We develop a new drug-drug interaction model and drug dose ontology called DIAKID (for drugs of T2DM and CKD). (2) Using comprehensive Semantic Web Rule Language (SWRL) rules, we automatically extract the correct drug dose, K-raising drugs, and drug-drug interaction warnings based on the Glomerular Filtration Rate (GFR) value of T2DM and CKD patients. The proposed work achieves very competitive results, and this is the first time such a study conducted on both diseases. The proposed system will guide clinicians in preparing prescriptions by giving necessary warnings about drug-drug interactions and doses.
Funder
Istanbul Technical University
Publisher
Springer Science and Business Media LLC
Reference89 articles.
1. The top 10 causes of death, [online] Available: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death, retrieved 3 January 2023
2. Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73–81.
3. Di Lullo L, Mangano M, Ronco C, Barbera V, De Pascalis A, Bellasi A, Cozzolino M. The treatment of type 2 diabetes mellitus in patients with chronic kidney disease: What to expect from new oral hypoglycemic agents. Diabetes Metab Syndr. 2017;11:295–305.
4. Diabetes and the kidneys, [online] Available: https://www.idf.org/our-activities/care-prevention/diabetes-and-the-kidney.html, retrieved 3 January 2023
5. Belderrar A, Hazzab A. Real-time estimation of hospital discharge using fuzzy radial basis function network and electronic health record data. Int J Med Eng Inform. 2021;13(1):75–83.